Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy
Oncolytic viruses (OVs) are emerging as promising and potential anti-cancer therapeutic agents, not only able to kill cancer cells directly by selective intracellular viral replication, but also to promote an immune response against tumor. Unfortunately, the bioavailability under systemic administra...
Main Authors: | Siyuan Deng, Alessandra Iscaro, Giorgia Zambito, Yimin Mijiti, Marco Minicucci, Magnus Essand, Clemens Lowik, Munitta Muthana, Roberta Censi, Laura Mezzanotte, Piera Di Martino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/1/144 |
Similar Items
-
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01) -
The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01) -
Potent anti-tumor immunostimulatory biocompatible nanohydrogel made from DNA
by: Jiana Jiang, et al.
Published: (2019-06-01) -
Protein-Based Nanohydrogels for Bioactive Delivery
by: Subhash Chander, et al.
Published: (2021-07-01) -
Hyaluronan-Based Nanohydrogels as Effective Carriers for Transdermal Delivery of Lipophilic Agents: Towards Transdermal Drug Administration in Neurological Disorders
by: Seong Uk Son, et al.
Published: (2017-12-01)